EsoCap AG organized a multidisciplinary scientific advisory board meeting in Zurich with thirteen international experts on June 27, 2019.
As an introduction, Prof. Werner Weitschies, Center for Drug Absorption and Transport at the University of Greifswald, gave a presentation on the Esophageal Wafer Study conducted in healthy volunteers by the University of Greifswald. The excellent results regarding acceptability and functionality were shared with the experts.
EsoCap AG presented the clinical development approach for its unique drug delivery technology in the first indication, EOE (eosinophilic esophagitis). The experts discussed the role of EsoCap’s technology for the topical treatment of EoE and explored the broader application of EsoCap’s drug delivery platform in reflux disease and Barrett’s esophagus.
